Anesthetic Effect - Pipeline Review, H2 2018

Global Markets Direct’s, ‘Anesthetic Effect - Pipeline Review, H2 2018’, provides an overview of the Anesthetic Effect pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anesthetic Effect, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Anesthetic Effect

- The report reviews pipeline therapeutics for Anesthetic Effect by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Anesthetic Effect therapeutics and enlists all their major and minor projects

- The report assesses Anesthetic Effect therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Anesthetic Effect

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Anesthetic Effect

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Anesthetic Effect pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Biolab Farmaceutica Ltda

Crescita Therapeutics Inc

Drawbridge Pharmaceuticals Pty Ltd

Expanesthetics Inc

Grunenthal GmbH

Lannett Company Inc

Lee's Pharmaceutical Holdings Ltd

MedinCell SA

Paion AG ...

Biolab Farmaceutica Ltda

Crescita Therapeutics Inc

Drawbridge Pharmaceuticals Pty Ltd

Expanesthetics Inc

Grunenthal GmbH

Lannett Company Inc

Lee's Pharmaceutical Holdings Ltd

MedinCell SA

Paion AG

Phosphagenics Ltd

Physica Pharma

Recro Pharma Inc

Sichuan Kelun Pharmaceutical Co Ltd

SiteOne Therapeutics Inc

Sphaera Pharma Pte Ltd

YiChang Humanwell Pharmaceutical Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Anesthetic Effect – Overview

Anesthetic Effect – Therapeutics Development

Pipeline Overview

Pipeline ...

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Anesthetic Effect – Overview

Anesthetic Effect – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Anesthetic Effect – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Anesthetic Effect – Companies Involved in Therapeutics Development

Biolab Farmaceutica Ltda

Crescita Therapeutics Inc

Drawbridge Pharmaceuticals Pty Ltd

Expanesthetics Inc

Grunenthal GmbH

Lannett Company Inc

Lee's Pharmaceutical Holdings Ltd

MedinCell SA

Paion AG

Phosphagenics Ltd

Physica Pharma

Recro Pharma Inc

Sichuan Kelun Pharmaceutical Co Ltd

SiteOne Therapeutics Inc

Sphaera Pharma Pte Ltd

YiChang Humanwell Pharmaceutical Co Ltd

Anesthetic Effect – Drug Profiles

(bupivacaine + neosaxitoxin) – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(lidocaine + prilocaine) – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

alphaxalone – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Aom-0498 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Aom-0765 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

cocaine hydrochloride – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

cysteine – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

EXPS-01 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

EXPS-05 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

EXPS-09 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Flexicaine – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

fospropofol disodium – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HSK-3486 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

KL-100137 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

lidocaine – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

lidocaine hydrochloride – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MDC-CMV – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

PHY-301 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

propofol – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

propofol – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

propofol – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

propofol – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

remimazolam – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

RP-2000 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Block NaV1.7 for Local Anesthetic Effect – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit NMDA Receptor for Anesthesia – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SPR-819 – Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Anesthetic Effect – Dormant Projects

Anesthetic Effect – Discontinued Products

Anesthetic Effect – Product Development Milestones

Featured News & Press Releases

Oct 08, 2018: PAION announces clinical development progress with Remimazolam by its partner Hana Pharm in South Korea

Jul 24, 2018: PAION starts EU Phase III trial with remimazolam in general anesthesia

Apr 30, 2018: Recro Pharma Presents Data for Neuromuscular Blocking and Reversal Agents at the AUA 2018 Annual Meeting

Mar 20, 2018: Phosphagenics/Terumo R&D alliance to focus on TPM Injectables: TPM/Oxymorphone Patch Development to move outside Agreement

Nov 23, 2017: PAION Announces Clinical Development Progress with Remimazolam by its Partner Hana Pharma in South Korea

Nov 09, 2017: Phosphagenics Provides Update on TPM/Propofol Development Program

Sep 28, 2017: European Patent Office Grants Formulation Patent For Remimazolam In The EU

Mar 09, 2017: China FDA has Approved Zingo for Pediatric Use Needle-free Local Analgesia as Priority Review for Clinical Trial

Nov 14, 2016: Powder Pharmaceuticals Submits New Drug Application to China FDA and Hong Kong Department of Health for Needle-free Local Analgesia

Oct 19, 2016: Positive Remimazolam Phase III Colonoscopy Results Presented at the 2016 American College of Gastroenterology Annual Scientific Meeting

Sep 22, 2016: PAION: Remimazolam Phase III Colonoscopy Data to Be Presented at the American College of Gastroenterology 2016 Meeting

Sep 06, 2016: PAION announces clinical development progress with remimazolam by its Partner Yichang Humanwell in China

Jun 19, 2016: Paion Reports Positive Remimazolam Headline Data In Pivotal U.S. Phase III Study In Procedural Sedation For Colonoscopy

Feb 18, 2016: PAION reports about positive pre-NDA meeting with Japanese authority PMDA

Feb 09, 2016: Paion Discontinues European Remimazolam Phase III Trial In Cardiac Surgery Patients Due To Insufficient Recruitment

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

List of Tables

Number of Products under Development for Anesthetic Effect, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products ...

List of Tables

Number of Products under Development for Anesthetic Effect, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products under Development by Universities/Institutes, H2 2018

Products under Development by Companies, H2 2018

Products under Development by Companies, H2 2018 (Contd..1), H2 2018

Products under Development by Universities/Institutes, H2 2018

Number of Products by Stage and Target, H2 2018

Number of Products by Stage and Mechanism of Action, H2 2018

Number of Products by Stage and Route of Administration, H2 2018

Number of Products by Stage and Molecule Type, H2 2018

Anesthetic Effect – Pipeline by Biolab Farmaceutica Ltda, H2 2018

Anesthetic Effect – Pipeline by Crescita Therapeutics Inc, H2 2018

Anesthetic Effect – Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H2 2018

Anesthetic Effect – Pipeline by Expanesthetics Inc, H2 2018

Anesthetic Effect – Pipeline by Grunenthal GmbH, H2 2018

Anesthetic Effect – Pipeline by Lannett Company Inc, H2 2018

Anesthetic Effect – Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2018

Anesthetic Effect – Pipeline by MedinCell SA, H2 2018

Anesthetic Effect – Pipeline by Paion AG, H2 2018

Anesthetic Effect – Pipeline by Phosphagenics Ltd, H2 2018

Anesthetic Effect – Pipeline by Physica Pharma, H2 2018

Anesthetic Effect – Pipeline by Recro Pharma Inc, H2 2018

Anesthetic Effect – Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H2 2018

Anesthetic Effect – Pipeline by SiteOne Therapeutics Inc, H2 2018

Anesthetic Effect – Pipeline by Sphaera Pharma Pte Ltd, H2 2018

Anesthetic Effect – Pipeline by YiChang Humanwell Pharmaceutical Co Ltd, H2 2018

Anesthetic Effect – Dormant Projects, H2 2018

Anesthetic Effect – Dormant Projects, H2 2018 (Contd..1), H2 2018

Anesthetic Effect – Discontinued Products, H2 2018

List of Figures

List of Figures

Number of Products under Development for Anesthetic Effect, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products ...

List of Figures

Number of Products under Development for Anesthetic Effect, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products by Top 10 Targets, H2 2018

Number of Products by Stage and Top 10 Targets, H2 2018

Number of Products by Top 10 Mechanism of Actions, H2 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018

Number of Products by Routes of Administration, H2 2018

Number of Products by Stage and Routes of Administration, H2 2018

Number of Products by Stage and Molecule Types, H2 2018

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports